Stock ICU SEASTAR MEDICAL HOLDING CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

News SeaStar Medical Holding Corporation

Equities

ICU

US81256L2034

Market Closed - Nasdaq
Other stock markets
 01:00:00 2024-07-03 pm EDT 		5-day change 1st Jan Change
9.11 USD +2.71% Intraday chart for SeaStar Medical Holding Corporation +32.22% -17.69%
Jul. 03 SeaStar Medical Says US FDA Agrees to Final Labeling for Quelimmune MT
Jul. 03 SeaStar Medical Holding Corporation Finalizes FDA Labeling Requirement for QUELIMMUNE, Paving the Way for First Commercial Sales as Humanitarian Use Device CI

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
SeaStar Medical Says US FDA Agrees to Final Labeling for Quelimmune
MT
SeaStar Medical Finalizes FDA Labeling Requirement for QUELIMMUNE, Paving the Way for First Commercial Sales as Humanitarian Use Device
AQ
SeaStar Medical Holding Corporation Finalizes FDA Labeling Requirement for QUELIMMUNE, Paving the Way for First Commercial Sales as Humanitarian Use Device
CI
SeaStar Medical’s Selective Cytopheretic Device Featured in Two Presentations at the 42nd Vicenza Course AKI-CRT-ECOS and Critical Care Nephrology
AQ
SeaStar Medical Holding Corporation Announces Board Changes
CI
SeaStar Medical Strengthens Board of Directors and Transitions to Commercial-Stage Company
AQ
Article in Nature Scientific Reports Describes Mechanism of Action of SeaStar Medical’s Selective Cytopheretic Device in the Immunomodulation of Excessive Inflammation
AQ
SeaStar Medical to Present at the Virtual Emerging Growth Conference on June 12, 2024
AQ
SeaStar Medical Announces 25-for-1 Reverse Stock Split
AQ
SeaStar Medical Holding Corporation Approves Class II Director Appointments
CI
Manuscript Published on Multiorgan Failure Patients Treated with SeaStar Medical’s Selective Cytopheretic Device Who Achieved Transplant Eligibility
AQ
SeaStar Medical Holding Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
SeaStar Medical Reports First Quarter 2024 Financial Results and Provides a Business Update
AQ
SeaStar Medical Announces $3.6 Million NIH Grant Award to Study the Selective Cytopheretic Device in Adult Patients with Severe Chronic Heart Failure
AQ
SeaStar Medical Announces $3.6 Million NIH Grant Award to Study the Selective Cytopheretic Device in Adult Patients with Severe Chronic Heart Failure
CI
Pomerantz Law Firm Investigates Claims on Behalf of Investors of SeaStar Medical Holding Corporation - ICU
PR
Pomerantz Law Firm Investigates Claims on Behalf of Investors of SeaStar Medical Holding Corporation - ICU
PR
SeaStar Medical Reports 2023 Financial Results and Provides a Business Update
AQ
SeaStar Medical Holding Corporation Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Pomerantz Law Firm Investigates Claims on Behalf of Investors of SeaStar Medical Holding Corporation - ICU
PR
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ICU Stock
  4. News SeaStar Medical Holding Corporation